
Key updates for TR in the 2025 ESC/EACTS Guidelines for the management of valvular heart disease
Download
Help your patients learn about tricuspid disease and the potential treatment options and outcomes. Your patients could start a new chapter of life with transcatheter tricuspid valve interventions (TTVIs).


Learn about the latest guidelines for TR, as well as outcomes from randomised controlled trials and single-arm studies.

For a listing of indications, contraindications, precautions, warnings and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
PP--EU-10652 v2.0.
Gain the latest insights from Edwards Lifesciences to stay informed about TR and TTVI.
Sign up for the newsletter for valuable resources including: